The Apogee
The Apogee
  • Home
  • From Courts
  • Global
  • Technology
  • Business
  • Law
  • Judgements
    • High Court
    • Supreme Court
  • Achievers
  • Video
  • More
    • Interviews
    • Opinion/Features
    • Research
    • Science
    • Environs
    • Health
  • test-series
  1. Home
  2. Economy
  3. SpiceJet to start trial of digital health verification app
 SpiceJet to start trial of digital health verification app
SpiceJet. (Photo: Twitter/@flyspicejet)
Economy

SpiceJet to start trial of digital health verification app

by Newsdesk August 20, 2021

AA

New Delhi, Aug 20 (IANS) Budget airline SpiceJet will begin trial for the Travel Pass mobile app of the International Air Transport Association (IATA) for digital health verification.

The trial will be conducted on Mumbai to Male flights effective August 23.

The IATA Travel Pass is a mobile application that aides travellers to store and manage their verified certifications for Covid-19 tests or vaccinations.

The Travel Pass is meant to manage and verify the traveller’s Covid-19 status in line with the governments’ health and other requirements.

SpiceHealth has been on-boarded by IATA as a lab partner for the Travel Pass trial. SpiceHealth is a healthcare company founded by the promoters of SpiceJet.

At present, SpiceHealth operates 21 labs and collection centres for RT-PCR and rapid antigen testing spread across 11 cities in India.

According to Ajay Singh, Chairman and Managing Director, SpiceJet, the introduction of Travel Pass will make the verification process simple and hassle-free, boost both passenger confidence and make international travel more efficient and secure.

Previous post
Next post

Latest Post

From Courts

Nagpur Bench of Bombay High Court quashes false rape and dowry case against would be husband

May 13, 2024
From Courts

SC asks Patanjali to place on record IMA chief’s interview terming apex court observations as ‘unfortunate’

April 30, 2024
From Courts

Delhi HC restrains Ashneer Grover from creating third party rights in BharatPe shares

April 30, 2024
Global

AstraZeneca admits Covishield jab raises TTS risk. Should you be worried?

April 30, 2024
Copyright © 2026 Qoxag. All Right Reserved.
Go to mobile version